Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

stallergenes - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense top - unii:s7pw24bx20, phleum pratense pollen - unii:65m88rw2eg), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), lolium perenne pollen (unii: 4t81lb52r0) (lolium perenne pollen - unii:4t81lb52r0) - anthoxanthum odoratum pollen 100 [ir] - oralair is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific ige antibodies for any of the five grass species contained in this product. oralair is approved for use in persons 5 through 65 years of age. oralair is not indicated for the immediate relief of allergy symptoms. oralair is contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic allergic reaction - history of any severe local reaction to sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients (mannitol, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate and lactose monohydrate) contained in this product [ see description (11) ] risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

cenexi hsc - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense top - unii:s7pw24bx20, phleum pratense pollen - unii:65m88rw2eg), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), lolium perenne pollen (unii: 4t81lb52r0) (lolium perenne pollen - unii:4t81lb52r0) - oralair is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific ige antibodies for any of the five grass species contained in this product. oralair is approved for use in persons 5 through 65 years of age. oralair is not indicated for the immediate relief of allergy symptoms. oralair is contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic allergic reaction - history of any severe local reaction to sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients (mannitol, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate and lactose monohydrate) contained in this product [ see description (11) ] risk summary all pregnancies have a risk of birth defect, loss, or other a

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

milestone chemicals australia pty. ltd. - alkaline salts - soluble powder - alkaline salts cleanser/sanitiser active 940.0 g/kg - dairy cleanser - dairy equipment stainless steel | milking equipment | milking machine - residue, dirt in milking equipment

Australija - engleski - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - carbon dioxide, quantity: 1 ml/ml - gas, medicinal - excipient ingredients: - as an anaesthetic supplement in various clinical circumstances to maintain optimum blood carbon levels, facilitate blind intubations and rapidly increase depth of anaesthesia with volatile agents. as a respiratory stimulant after apnoea or after relief of chronic respiratory obstruction. to prevent hypocapnia during hyperventilation. use in clinical and physiological investigations including use as insufflation gas.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - nitrous oxide, quantity: 1 l/l - gas, medicinal - excipient ingredients: - indications as at 1 november 2001: nitrous oxide is indicated in adults and children for: 1. general anaesthesia, usually as an adjuvant to other volatile or intravenous anaesthetics; 2. analgesia (with oxygen) eg. dentistry and obstetrics.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - nitrous oxide, quantity: 0.5 l/l; oxygen, quantity: 0.5 l/l - gas, medicinal - excipient ingredients: - indications as at 31 october 2001: nitrous oxide with oxygen (nitronox) is indicated in adults and children for analgesia.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

nordan smith welding supply - air (unii: k21nzz5y0b) (air - unii:k21nzz5y0b) -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

airgas intermountain inc - air (unii: k21nzz5y0b) (air - unii:k21nzz5y0b) -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

general distributing company - air (unii: k21nzz5y0b) (air - unii:k21nzz5y0b) -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

praxair distribution southeast llc - air (unii: k21nzz5y0b) (air - unii:k21nzz5y0b) -